NCT05675410 2026-04-13A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNational Cancer Institute (NCI)Phase 3 Recruiting1,875 enrolled